Evidence
Ther Apher Dial. 2024 Apr 17. doi: 10.1111/1744-9987.14128. Online ahead of print.
ABSTRACT
INTRODUCTION: This study examined the impact of Coronavirus disease 2019 on anxiety, depression, and health-related quality of life (HRQOL) among Egyptian hemodialysis (HD) patients.
METHODS: This multicenter cross-sectional study was carried out in Egypt in the years 2021-2022, where 300 HD patients from four HD centers were allocated into two groups: post-COVID and non-COVID. The Hospital Anxiety and Depression Scale (HADS) and the Kidney Disease QOL-36 questionnaire were used to assess anxiety, depression, and QOL of the included patients.
RESULTS: In the post-COVID group, abnormal and borderline cases of anxiety and depression were detected in 38.6% and 62.5% of patients, respectively, with no statistically significant difference between both groups. The post-COVID group showed higher work status and lower sexual and physical functioning, which correlated negatively with anxiety and depression scores.
CONCLUSION: Past-COVID infection did not influence depression and anxiety symptoms in HD patients. Sexual and physical functioning were more affected among COVID-survivors.
PMID:38629237 | DOI:10.1111/1744-9987.14128
Add to Google Keep
Post to X
Share on Linkedin
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Post-COVID anxiety, depression, and quality of life among Egyptian hemodialysis patients
🌐 90 Days
VR Related Evidence Matrix
Evidence Blueprint
Post-COVID anxiety, depression, and quality of life among Egyptian hemodialysis patients
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Post-COVID anxiety, depression, and quality of life among Egyptian hemodialysis patients
🌐 365 Days
VR Related Evidence Matrix
